Indivior ( (GB:INDV) ) has shared an update.
Indivior PLC has announced the granting of Conditional Awards over Ordinary Shares under its 2024 Long-Term Incentive Plan to key managerial personnel. The vesting of these awards is contingent upon continued employment and the achievement of specific performance conditions, including relative Total Shareholder Return and market growth metrics. This move is part of Indivior’s strategy to align the interests of its leadership with company performance, potentially impacting its operational focus and market positioning.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and its co-occurring disorders. The company’s primary products include treatments for opioid use disorder, with a significant market focus on long-acting injectables and related therapies.
YTD Price Performance: -28.96%
Average Trading Volume: 330,357
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £906.9M
Learn more about INDV stock on TipRanks’ Stock Analysis page.